Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -23.70% is 82% above its 5-year average of -131.55%, near the high end of its 5-year range (-324.16%–-16.71%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.11% below its 12-month average of -23.68%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -23.70%.
RETURN ON EQUITY (ROE)
-23.70%
RETURN ON EQUITY (ROE) AVG TTM
-23.68%
RETURN ON EQUITY (ROE) AVG 3Y
-124.68%
RETURN ON EQUITY (ROE) AVG 5Y
-131.55%
RETURN ON EQUITY (ROE) AVG 10Y
-92.76%
RETURN ON EQUITY (ROE) AVG 15Y
-134.85%
RETURN ON EQUITY (ROE) AVG 20Y
-118.77%
CURRENT VS TTM AVG
-0.11%
CURRENT VS 3Y AVG
+80.99%
CURRENT VS 5Y AVG
+81.98%
CURRENT VS 10Y AVG
+74.44%
CURRENT VS 15Y AVG
+82.42%
CURRENT VS 20Y AVG
+80.04%
SECTOR MEDIAN · HEALTHCARE
-40.75%
median of 681 covered companies
CURRENT VS SECTOR MEDIAN
+41.83%
vs the sector median at left
Microbot Medical Inc.
Market Cap
$50.08M
Return on Equity (ROE)
-23.70%
TTM Avg
-23.68%
3Y Avg
-124.68%
5Y Avg
-131.55%
Market Cap
$50.51M
Return on Equity (ROE)
-90.44%
TTM Avg
-163.19%
3Y Avg
-112.62%
5Y Avg
-86.58%
Market Cap
$50.45M
Return on Equity (ROE)
N/A
TTM Avg
31.64%
3Y Avg
119.26%
5Y Avg
-26.51%
Market Cap
$50.54M
Return on Equity (ROE)
N/A
TTM Avg
296.81%
3Y Avg
-175.08%
5Y Avg
-1071.79%
Market Cap
$50.11M
Return on Equity (ROE)
-52.72%
TTM Avg
-32.48%
3Y Avg
-92.81%
5Y Avg
-85.98%
Market Cap
$50.66M
Return on Equity (ROE)
N/A
TTM Avg
-206.96%
3Y Avg
-221.50%
5Y Avg
-349.91%
Market Cap
$50.73M
Return on Equity (ROE)
N/A
TTM Avg
-382.07%
3Y Avg
-282.25%
5Y Avg
-171.00%
Market Cap
$49.52M
Return on Equity (ROE)
-42.01%
TTM Avg
-2.07%
3Y Avg
11.82%
5Y Avg
5.22%
Market Cap
$51.38M
Return on Equity (ROE)
-76.82%
TTM Avg
-798.41%
3Y Avg
-485.96%
5Y Avg
-324.45%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $50.08M | -23.70% | -23.68% | -124.68% | -131.55% |
| INmune Bio, Inc. (INMB)vs › | $50.51M | -90.44% | -163.19% | -112.62% | -86.58% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.45M | N/A | 31.64% | 119.26% | -26.51% |
| Clene Inc. (CLNN)vs › | $50.54M | N/A | 296.81% | -175.08% | -1071.79% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $50.11M | -52.72% | -32.48% | -92.81% | -85.98% |
| Celularity Inc. (CELU)vs › | $50.66M | N/A | -206.96% | -221.50% | -349.91% |
| Apollomics, Inc. (APLM)vs › | $50.73M | N/A | -382.07% | -282.25% | -171.00% |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.52M | -42.01% | -2.07% | 11.82% | 5.22% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.38M | -76.82% | -798.41% | -485.96% | -324.45% |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | -708.48% | 156.13% | 510.26% | 342.91% |
ROE
-23.7%
ROA
-22.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -23.70% |
| 2026-03-31 | -19.18% |
| 2025-12-31 | -16.95% |
| 2025-09-30 | -16.71% |
| 2025-06-30 | -41.86% |
| 2025-03-31 | -40.32% |
| 2024-12-31 | -324.16% |
| 2024-09-30 | -294.25% |
| 2024-06-30 | -172.35% |
| 2024-03-31 | -166.34% |
| 2023-12-31 | -238.61% |
| 2023-09-30 | -143.84% |
| 2023-06-30 | -122.58% |
| 2023-03-31 | -264.69% |
| 2022-12-31 | -180.66% |
| 2022-09-30 | -253.55% |
| 2022-06-30 | -153.58% |
| 2022-03-31 | -104.24% |
| 2021-12-31 | -78.67% |
| 2021-09-30 | -56.47% |
| 2021-06-30 | -49.75% |
| 2021-03-31 | -41.88% |
| 2020-12-31 | -37.72% |
| 2020-09-30 | -31.73% |
| 2020-06-30 | -27.49% |
| 2020-03-31 | -25.24% |
| 2019-12-31 | -22.98% |
| 2019-09-30 | -117.23% |
| 2019-06-30 | -92.48% |
| 2019-03-31 | -83.80% |
| 2018-12-31 | -545.41% |
| 2018-09-30 | -110.65% |
| 2018-06-30 | -82.02% |
| 2018-03-31 | -87.13% |
| 2017-12-31 | -76.16% |
| 2017-09-30 | -38.86% |
| 2017-06-30 | -59.87% |
| 2017-03-31 | -36.23% |
| 2016-12-31 | -22.29% |
| 2015-09-30 | -530.39% |
| 2015-06-30 | -201.96% |
| 2014-12-31 | -557.69% |
| 2014-09-30 | -187.06% |
| 2014-03-31 | -360.98% |
| 2013-12-31 | -176.81% |
| 2013-09-30 | -624.42% |
| 2013-06-30 | -358.30% |
| 2013-03-31 | -241.74% |
| 2012-12-31 | -203.73% |
| 2012-09-30 | -357.18% |
| 2012-06-30 | -390.34% |
| 2011-12-31 | -198.86% |
| 2011-09-30 | -165.10% |
| 2011-06-30 | -144.06% |
| 2011-03-31 | -124.04% |
| 2010-12-31 | -163.06% |
| 2010-09-30 | -92.30% |
| 2010-06-30 | -75.51% |
| 2010-03-31 | -92.79% |
| 2009-12-31 | -88.63% |
| 2009-09-30 | -126.39% |
| 2009-06-30 | -121.86% |
| 2009-03-31 | -156.53% |
| 2008-12-31 | -133.37% |
| 2008-09-30 | -150.19% |
| 2008-06-30 | -124.42% |
| 2008-03-31 | -93.52% |
| 2007-12-31 | -71.07% |
| 2007-09-30 | -56.77% |
| 2007-06-30 | -43.88% |
| 2007-03-31 | -39.46% |
| 2006-12-31 | -34.85% |
| 2006-09-30 | -32.84% |
| 2006-06-30 | -21.71% |
| 2006-03-31 | -44.24% |
| 2005-12-31 | -36.26% |
| 2005-09-30 | -35.86% |
| 2005-06-30 | -51.77% |
| 2005-03-31 | -46.98% |
| 2004-12-31 | -41.49% |
| 2004-09-30 | -78.05% |
| 2004-06-30 | -55.77% |
| 2004-03-31 | -152.33% |
| 2003-12-31 | -112.10% |
| 2003-09-30 | -210.53% |
| 2003-06-30 | -139.71% |
